Search images on Google      Product Monograph

Active Ingredients:

• tafasitamab, 200 MG/VIAL

DIN: 02518627

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription

Company: INCYTE CORPORATION

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01F - (ATC, WHO)
• L01FX - (ATC, WHO)
• L01FX12 - TAFASITAMAB (WHO)

 

External Links for Minjuvi:

Search on Google

• Minjuvi side effects
• Minjuvi dosage
• tafasitamab side effects
• tafasitamab dosage